Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOC3 Antikörper

Rockland 600-101-114 APOC3 Reaktivität: Human WB, ELISA, IHC, IP Wirt: Ziege Polyclonal unconjugated
Rockland
Produktnummer ABIN5596680
Hersteller Produkt- Nr.: 600-101-114
  • Target Alle APOC3 Antikörper anzeigen
    APOC3 (Apolipoprotein C-III (APOC3))
    Reaktivität
    • 46
    • 36
    • 31
    Human
    Wirt
    • 60
    • 9
    • 5
    Ziege
    Klonalität
    • 66
    • 8
    Polyklonal
    Konjugat
    • 31
    • 9
    • 8
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser APOC3 Antikörper ist unkonjugiert
    Applikation
    • 52
    • 29
    • 20
    • 14
    • 14
    • 12
    • 8
    • 7
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)
    Hersteller Produkt- Nr.
    600-101-114
    Hersteller
    Rockland
    Verwendungszweck
    APOLIPOPROTEIN C-III Antibody
    Kreuzreaktivität (Details)
    Typically less than 1 % cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards.
    Produktmerkmale
    Synonyms: goat anti-Apolipoprotein C-III antibody, ApoC-III, Apo-CIII antibody, Apolipoprotein C3, Apolipoprotein C III antibody
    Aufreinigung
    This product has been prepared by immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities.
    Sterilität
    Sterile filtered
    Immunogen

    Immunogen: produced from apoLipoprotein Type C-III derived from human plasma

    Immunogen Type: Native Protein

    Isotyp
    IgG
    Top Product
    Discover our top product APOC3 Primärantikörper
  • Applikationshinweise

    Immunohistochemistry Dilution: 1:50 - 1:200

    Application Note: Anti-Apolipoprotein antibodies have been tested in immunohistochemistry and used for indirect trapping ELISA for quantitation of antigen in serum using a standard curve, immunoprecipitation, immunohistochemistry, and for western blotting for highly sensitive qualitative analysis. When performing immunoblotting assays - do not block with blotto. Blotto formulations tend to contain apoLipoprotein Type C-III and will neutralize antibody activity.

    Western Blot Dilution: 1:500 - 1:5,000

    Immunoprecipitation Dilution: 1:100

    ELISA Dilution: 1:5,000 - 1:10,000

    Other: User Optimized

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.0 mg/mL
    Buffer

    Buffer: 0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at 4° C prior to opening.   This product is stable 4° C as an undiluted liquid.  Dilute only prior to immediate use.  For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20° C or below.  Avoid cycles of freezing and thawing. 
    Haltbarkeit
    12 months
  • Jansen, Cirak, van Scherpenzeel, Timal, Reunert, Rust, Pérez, Vicogne, Krawitz, Wada, Ashikov, Pérez-Cerdá, Medrano, Arnoldy, Hoischen, Huijben, Steenbergen, Quelhas, Diogo, Rymen, Jaeken, Guffon et al.: "CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation. ..." in: American journal of human genetics, Vol. 98, Issue 2, pp. 310-21, (2016) (PubMed).

    Takinami, Yoshimatsu, Uchiumi, Toyosaki-Maeda, Morita, Ishihara, Yamane, Fukuda, Okamoto, Numata, Fukui: "Identification of potential prognostic markers for knee osteoarthritis by serum proteomic analysis." in: Biomarker insights, Vol. 8, pp. 85-95, (2013) (PubMed).

  • Target
    APOC3 (Apolipoprotein C-III (APOC3))
    Andere Bezeichnung
    APOC3 (APOC3 Produkte)
    Hintergrund
    Background: Anti Apolipoprotein C-III antibody recognizes the gene product of APOC. Apolipoprotein C-III is a protein component of very low density lipoprotein (VLDL). APOC3 inhibits lipoprotein lipase and hepatic lipase, it is thought to inhibit hepatic uptake of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia. This antibody is suitable for cardiovascular research.
    Gen-ID
    345
    UniProt
    P02656
    Pathways
    Carbohydrate Homeostasis, Lipid Metabolism
Sie sind hier:
Kundenservice